Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Could Require Pediatric Cancer Drug Combo Studies Under Amended User Fee Bill
May 19 2022
•
By
Brenda Sandburg
Pediatric studies of investigational cancer drug combinations could be required by FDA under amended user fee bill • Source: Shutterstock
More from Clinical Trials
More from R&D